SIBO and IBS: Understanding the Connection Between These Overlapping Conditions

The relationship between SIBO and IBS is one of the most significant and actively debated topics in gastroenterology. For decades, IBS was treated as a condition with no identifiable organic cause, a diagnosis of exclusion given when all tests came back normal. The discovery that a substantial proportion of IBS patients have bacterial overgrowth in their small intestine has fundamentally changed how many clinicians approach these patients.

Understanding the connection between SIBO and IBS is important whether you have been diagnosed with one, the other, or both. This guide covers what the research tells us about the overlap, how to determine if SIBO might be driving your IBS symptoms, and how treatment approaches differ.

How Much Do SIBO and IBS Overlap?

The overlap between SIBO and IBS is substantial, though the exact numbers vary across studies. A pivotal study by Dr. Mark Pimentel at Cedars-Sinai Medical Center found that 78 percent of IBS patients tested positive for SIBO on lactulose breath testing. Other studies have reported lower figures, with meta-analyses generally placing the prevalence of SIBO in IBS patients between 30 and 80 percent.

This wide range reflects the challenges of diagnosis rather than true variability in the condition. Different studies use different breath test substrates (lactulose versus glucose), different diagnostic thresholds, and different patient populations. The SIBO breath test has inherent limitations that affect accuracy, and the lack of a universally accepted gold standard for SIBO diagnosis complicates comparisons between studies.

What is clear from the research is that SIBO is significantly more common in IBS patients than in the general population, and that treating SIBO in IBS patients frequently results in meaningful symptom improvement.

What Symptoms Do SIBO and IBS Share?

The symptom overlap between SIBO and IBS is extensive, which is precisely why SIBO went unrecognized as a contributor to IBS for so long.

Bloating is the most common shared symptom and is often the most distressing. Both conditions cause abdominal distension that typically worsens throughout the day and after meals. In SIBO, bloating is caused by gas production from bacterial fermentation. In IBS without SIBO, bloating may result from visceral hypersensitivity, where normal amounts of gas cause disproportionate discomfort, or from altered gut motility.

Abdominal pain is a diagnostic criterion for IBS and a common feature of SIBO. In both conditions, pain is often related to meals and may improve or worsen with bowel movements. The quality and location of pain are usually indistinguishable between the two conditions.

Altered bowel habits present differently depending on the subtype. IBS-D (diarrhea-predominant) symptoms overlap heavily with hydrogen-dominant SIBO, while IBS-C (constipation-predominant) symptoms overlap with methane-dominant SIBO (IMO). IBS-M (mixed) may involve alternating patterns driven by varying gas production.

Gas and flatulence are common to both conditions. SIBO tends to produce more gas overall because of the sheer volume of fermentation occurring in the small intestine. IBS patients without SIBO may still experience significant gas from colonic fermentation of FODMAPs.

Fatigue and brain fog are reported by patients with both conditions but may be more pronounced in SIBO due to the malabsorption of nutrients and the systemic effects of bacterial metabolites entering the bloodstream.

When Should You Suspect SIBO If You Have IBS?

Not every IBS patient has SIBO, and SIBO testing is not always necessary. However, certain clinical clues increase the likelihood that SIBO is contributing to your IBS symptoms.

Your IBS began after food poisoning. Post-infectious IBS is one of the strongest risk factors for SIBO. Food poisoning can trigger an autoimmune response that damages the nerves controlling the migrating motor complex, leading to impaired gut motility and conditions favorable for bacterial overgrowth. If you can trace the onset of your IBS symptoms to a specific episode of gastroenteritis, SIBO testing is strongly recommended.

You are not responding to the low-FODMAP diet. The low-FODMAP diet is effective for approximately 75 percent of IBS patients. If you have followed the elimination phase carefully with minimal improvement, SIBO may be the reason. The diet reduces SIBO symptoms but does not eliminate the overgrowth, so patients with significant SIBO may see only partial benefit from dietary changes alone.

Bloating is your dominant symptom. While bloating occurs in most IBS subtypes, disproportionate bloating, especially with visible abdominal distension, is more suggestive of SIBO than of IBS alone.

You have IBS-C with significant bloating. Methane-dominant SIBO is strongly associated with constipation and bloating. The SIBO guide explains how methane directly slows gut motility.

You have risk factors for SIBO. Prior abdominal surgery (especially if adhesions are suspected), chronic PPI use (which reduces the stomach acid barrier against bacterial entry), diabetes or other conditions affecting gut motility, and immunodeficiency all increase SIBO risk.

You have nutritional deficiencies. Iron deficiency, B12 deficiency, and fat-soluble vitamin deficiencies are more common in SIBO than in IBS alone because SIBO impairs nutrient absorption in the small intestine.

How Does Diagnosis Differ Between SIBO and IBS?

IBS is diagnosed clinically using the Rome IV criteria, which require recurrent abdominal pain at least one day per week over three months associated with changes in stool frequency or form. There is no definitive test for IBS. It remains a diagnosis of exclusion.

SIBO is diagnosed through breath testing, which measures hydrogen, methane, and in newer tests, hydrogen sulfide gas in exhaled breath after ingesting a test substrate. The breath test is the most accessible non-invasive diagnostic tool, though it has limitations including moderate sensitivity and specificity.

The diagnostic approaches are not mutually exclusive. A patient can meet Rome IV criteria for IBS and simultaneously test positive for SIBO. In fact, this dual diagnosis is common. The question is whether SIBO is the primary driver of symptoms, a contributing factor, or an incidental finding.

How Does Treatment Differ Between SIBO and IBS?

This is where the distinction matters most. IBS and SIBO, while sharing symptoms, require different primary treatment strategies.

IBS treatment focuses on symptom management through the low-FODMAP diet, stress management, gut-directed hypnotherapy, antispasmodics, and targeted medications for specific symptoms (loperamide for diarrhea, osmotic laxatives for constipation). The emphasis is on identifying triggers and managing the gut-brain axis. The FODMAP lifestyle guide and the FODMAP tracker guide cover these approaches in detail.

SIBO treatment requires active eradication of the bacterial overgrowth through antimicrobial therapy, either pharmaceutical antibiotics or herbal antimicrobials. This is followed by a prevention phase using prokinetics, meal spacing, and dietary maintenance. Simply managing symptoms without addressing the overgrowth leads to persistent and potentially worsening disease.

When both conditions coexist, the recommended approach is to treat the SIBO first and then reassess. Many patients find that their IBS symptoms improve substantially or resolve entirely once the SIBO is eradicated. Others find that SIBO treatment improves some symptoms (particularly bloating and gas) while residual IBS symptoms (like visceral hypersensitivity or anxiety-related gut dysfunction) require ongoing management.

Can Treating SIBO Cure IBS?

This question generates passionate debate in the gastroenterology community. Some practitioners, particularly those in the functional medicine space, argue that SIBO is the root cause of many IBS cases and that eradicating it can effectively cure the condition. Others, typically in conventional gastroenterology, view SIBO as one of many potential contributors to IBS symptoms, not the sole cause.

The evidence supports a middle ground. Treating SIBO in IBS patients frequently results in significant symptom improvement. Studies show that IBS patients who achieve SIBO eradication have higher rates of symptom resolution than those who do not. However, relapse is common (highlighting the need for ongoing prevention strategies), and some patients retain IBS symptoms even after successful SIBO eradication.

The most balanced approach is to test for SIBO if clinical clues suggest it, treat it if found, and then manage any residual IBS symptoms with standard IBS strategies. This combination approach addresses both the bacterial overgrowth and the broader sensorimotor dysfunction that characterizes IBS.

How Can You Manage Both Conditions Day to Day?

Managing the IBS-SIBO overlap requires attention to both conditions in daily life. The low-FODMAP approach for SIBO addresses the dietary component. Meal spacing of 4 to 5 hours supports the MMC. Stress management supports the gut-brain axis. Prokinetics support motility. And ongoing monitoring helps catch early signs of relapse.

FODMAPSnap was designed to support patients managing exactly this kind of complexity. The app provides instant FODMAP analysis of meals, tracks symptoms, and includes dedicated SIBO profile support with treatment phase tracking and bacteria type specification. Whether you are managing IBS, SIBO, or both, having a tool that helps you navigate food choices in real time reduces the cognitive burden of dietary management.

For a comprehensive overview of SIBO types, testing, and treatment, visit our SIBO guide. The IBS and SIBO education hub provides additional educational resources on both conditions. For specific dietary guidance during SIBO treatment, the SIBO diet plan covers each treatment phase in detail.

---

This article is for informational purposes only and does not constitute medical advice. Both IBS and SIBO require proper diagnosis by a qualified healthcare provider. Do not self-diagnose or self-treat. If you suspect you may have SIBO, discuss testing options with your gastroenterologist or primary care provider.